Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.91
+0.02 (0.25%)
Sep 16, 2026, 4:00 PM EDT - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $239.32 million as of September 16, 2026. Its market cap has decreased by -5.99% in one year.
Market Cap
239.32M
Enterprise Value
155.57M
1-Year Change
-5.99%
Ranking
Category
Stock Price
$7.91
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $239.32M, an increase of 44.11%. That is a compound annual growth rate of 13.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 239.32M | 27.65% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 262.49M |
| Foghorn Therapeutics | 258.92M |
| Entrada Therapeutics | 254.20M |
| Alector | 246.76M |
| Anavex Life Sciences | 241.01M |
| NervGen Pharma | 236.01M |
| Greenwich LifeSciences | 235.59M |
| Compugen | 234.92M |